Results 271 to 280 of about 31,062 (287)
Heart failure (HF) and atrial fibrillation (AF) are major global health challenges with rising prevalence and significant morbidity, mortality, and healthcare burden. Despite advances in HF management, AF remains a critical comorbidity that worsens outcomes and requires ad hoc treatment strategies, increasing the risk of non‐adherence and side effects.
Mark Luedde +24 more
wiley +1 more source
Left Atrial Dysfunction in Patients with Atrial Fibrillation and Heart Failure. [PDF]
Trankle CR +5 more
europepmc +1 more source
In a large cohort of patients with newly diagnosed transthyretin amyloid cardiomyopathy (ATTR‐CM), echocardiographic apical sparing was associated with increased left ventricular amyloid load and atrial remodelling. Quantitative biopsy analysis revealed that Perugini scores often failed to accurately reflect myocardial amyloid burden.
Thomas Krammer +21 more
wiley +1 more source
Association of Long-Term Body Mass Index Variability With the Development of Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction Across Patterns of Weight Change. [PDF]
Yu Z +10 more
europepmc +1 more source
P15 | Heart failure with reduced ejection fraction (HFrEF) and iron deficiency
openalex +1 more source
Effects of empagliflozin on sodium and fluid regulation in chronic heart failure (CHF). EF, ejection fraction; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide NYHA, New York Heart Association. Aims Sodium–glucose co‐transporter 2 inhibitors have become a cornerstone in managing chronic heart failure (CHF).
Venera Bytyqi +11 more
wiley +1 more source
Evidence-based medical therapies for acute heart failure in Cameroon: a retrospective analysis of prescription patterns at Laquintinie Hospital, Douala, 2022-2024. [PDF]
Siddikatou D +12 more
europepmc +1 more source
Pathophysiologic mechanisms of heart failure (HF) (i.e. renin–angiotensin–aldosterone system [RAAS], congestion, and inflammation), together with patient‐related factors such as diabetes, hypertension, and chronic kidney disease (CKD), contribute to kidney function decline and glomerular or tubular injury.
Masatake Kobayashi +14 more
wiley +1 more source

